What's the 'true' rate of dislocation after total hip replacement?

December 18, 2020

December 18, 2020 - The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

In the first two years following total hip arthroplasty (THA), the "true" rate of hip dislocation is 3.5 percent, according to the report by Lars L. Hermansen, MD, of Hospital of South West Jutland, Esbjerg, Denmark, and colleagues. "Since our results are based on a large cohort over a five-year inclusion period and include all hospital contacts in Denmark within the first two years after THA, we believe to have found the 'true' occurrence of dislocation within this patient group and time frame," the researchers write.

'Comprehensive' approach needed to capture true risks of dislocation after THA

Hip dislocation is a common and devastating complication following THA and is one of the leading reasons for revision. Previous studies have reported widely varying rates of dislocation following THA, reflecting differences in study methods and patient populations. Some dislocations may be treated without a surgical procedure or hospital admission; other patients may undergo revision at a different hospital than where the primary THA was performed.

Dr. Hermansen and colleagues sought to develop a "more thorough and comprehensive method" for estimating the actual cumulative incidence of dislocation. With use of a national database (the Danish Hip Arthroplasty Register), the researchers identified 31,105 cases of primary THA for osteoarthritis performed in Denmark between 2012 and 2014.

The researchers then used a nationwide hospital database (the Danish National Patient Register) to identify patients who underwent treatment for hip dislocation within two years after primary THA. The study used a two-year window because most dislocations of primary hip replacements occur within that time.

"Our review of patient files identified 1,861 dislocations in 1,079 THAs, which corresponds to a two-year cumulative incidence of 3.5 percent," Dr. Hermansen and coauthors write. More than 40 percent of these patients had at least two dislocations. Three-fourths of initial dislocations occurred within the first three months postoperatively.

By linking the hip replacement registry to the national patient database, the researchers identified many dislocations that would otherwise have been missed. Several additional cases were identified by reviewing alternative procedure codes in patient files. The "true" rate of 3.5 percent "was a 50 percent increase compared with the correctly coded dislocations captured by administrative register-data only," the researchers write.

The study also looked at risk factors for dislocation following primary THA. Risk was lower in patients younger than 65 years old, higher in those over 75 years old, and lower in men than women. Patients in better health (according to the American Society of Anesthesiologists Physical Status Classification System) were also at lower risk of dislocation.

Several surgical factors were also associated with a lower risk of dislocation: cemented fixation, lateral surgical approach, larger femoral head size, and use of dual-mobility cups. The researchers note that a large majority of patients underwent THA via the posterior approach, which is more commonly used in Denmark compared to other countries.

The results suggest that rates of hip dislocation following THA - as shown by in-depth analysis of unique and comprehensive Danish health databases - are higher than suggested by administrative hospital data only. Dr. Hermansen and colleagues conclude: "Comprehensive search algorithms are needed in order to identify all dislocations so that this complication can be accurately reported in national registers."

DOI: 10.2106/JBJS.19.01352

About The Journal of Bone & Joint Surgery

The Journal of Bone & Joint Surgery(JBJS) has been the most valued source of information for orthopaedic surgeons and researchers for over 125 years and is the gold standard in peer-reviewed scientific information in the field. A core journal and essential reading for general as well as specialist orthopaedic surgeons worldwide, The Journal publishes evidence-based research to enhance the quality of care for orthopaedic patients. Standards of excellence and high quality are maintained in everything we do, from the science of the content published to the customer service we provide. JBJS is an independent, non-profit journal.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit

For more information, visit

Wolters Kluwer Health

Related December Articles from Brightsurf:

COVID-19 may have been in LA as early as last December, UCLA-led study suggests
UCLA researchers and colleagues who analyzed electronic health records found that there was a 50% increase in patients with coughs and acute respiratory failure at UCLA Health hospitals and clinics beginning in late December 2019 and continuing into February, suggesting that COVID-19 may have been circulating in the area months before the first definitive cases in the U.S. were identified.

Early pandemic paradox: fewer UK deaths from December 2019 to March 2020 compared to the previous 5 years
An analysis of national weekly mortality rates between December 2019 - March 2020, compared to the same period for the previous five years, by researchers at WMG and WMS, University of Warwick, has shown that there have been fewer deaths registered this year during the lead up to the Covid-19 pandemic.

Story tips from the Department of Energy's Oak Ridge National Laboratory, December 2019
ORNL story tips: An additively manufactured polymer layer applied to specialized plastic proved effective to protect aircraft from lightning strikes in lab test; injecting shattered argon pellets into a super-hot plasma, when needed, could protect a fusion reactor's interior wall from runaway electrons; ORNL will celebrate the life and legacy of Dr.

December's SLAS Discovery special issue now available
The December issue of SLAS Discovery features part two of the two-part special issue, ''Membrane Proteins: New Approaches to Probes, Technologies and Drug Design.''

December's SLAS technology feature article now available
Next month's SLAS Technology features the cover article, 'Automated System for Small-Population Single-Particle Processing Enabled by Exclusive Liquid Repellency,' outlining research led by Chao Li, Ph.D., (University of Wisconsin-Madison, USA)

November/December 2015 Annals of Family Medicine tip sheet
This tip sheet features synopsis of original research and commentary published in the November/December 2015 issue of Annals of Family Medicine.

Evidence says: December symposium showcases forensics at NIST
To spotlight how the National Institute of Standards and Technology (NIST) currently serves the forensics community, the agency is hosting Forensics@NIST 2014 on Dec.

New research on diverticular disease in the December issue of Clinical Gastroenterology and Hepatology
The December issue of Clinical Gastroenterology and Hepatology, the official practice journal of the American Gastroenterological Association, fills a critical research gap in diverticulosis research.

Median follow-up results from the ALTITUDE study, stopped prematurely in December 2011
Preliminary results from the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) do not support administration of aliskiren on top of standard therapy with renin-angiotensin-aldosterone system blockade in type 2 diabetics at high risk of cardiovascular and renal events, according to Professor Hans-Henrik Parving from Rigshospitalet, University of Copenhagen, Denmark.

December 2011 Geology highlights
Articles in the December 2011 issue of Geology include the discovery of microfossils in the Tayshir Formation, Mongolia; Examination of sediments in a deep crater lake on Kilimanjaro to understand past environmental change in East Africa; Determination of the timing of favorable environmental conditions that would allow human migration across southern Arabia; and zircon dating results in Jack Hills, Australia, that are expected to spark debate on the true nature of the Hadean Earth.

Read More: December News and December Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.